Loading organizations...
§ Private Profile · San Jose, CA, USA
Medtech company developing transdermal patch technology for non-toxic iron transportation to treat iron-deficiency anemia patients.
Fe3 Medical is a San Antonio, Texas-based medtech company developing a transdermal patch technology for the non-toxic delivery of iron across the skin to treat iron-deficiency anemia. The proprietary system provides an alternative for patients unable to tolerate oral iron supplementation by bypassing the gastrointestinal tract to eliminate associated side effects. The enterprise reached an estimated valuation of $14 million to $21 million following the close of a $14.5 million Series B financing round in 2016. This funding included capital from the State of Texas and the Texas Emerging Technology Fund, alongside board representation from Joseph Siletto of Sweet Water Capital. Led by Chief Executive Officer Mark Sieczkarek, the organization is utilizing its venture backing to advance clinical trials and pursue regulatory clearances like FDA approval. The company was founded by Mir of InCube Labs.
Fe3 Medical has raised $14.5M across 2 funding rounds.
Fe3 Medical has raised $14.5M in total across 2 funding rounds.
Fe3 Medical has raised $14.5M in total across 2 funding rounds.
Fe3 Medical's investors include Huagai Capital, InCube Ventures, Jianmin Pharmaceuticals, Ping An Ventures, Joseph Siletto, Mir Imran.
Fe3 Medical has raised $14.5M across 2 funding rounds. Most recently, it raised $3.5M Series B Extension in August 2016.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 15, 2016 | $3.5M Series B Plus | — | Huagai Capital, InCube Ventures, Jianmin Pharmaceuticals, Ping AN Ventures, Joseph Siletto | Announced |
| Mar 2, 2016 | $11M Series B | — | MIR Imran, Jianmin Pharmaceuticals, Ping AN Ventures | Announced |